| Active substance | Gliclazide | 
|---|---|
| Storage conditions | Store at room temperature away from moisture and heat | 
| Side effects | Hypoglycemia, gastrointestinal disturbances (e.g., nausea, indigestion), dizziness, headache | 
| Effects | Lowers blood glucose levels by stimulating insulin release from pancreatic beta cells | 
| Dosage (sports) | Not applicable | 
| Dosage (medical) | Typically 40-120 mg per day, depending on patient response and formulation (immediate or extended release) | 
| Half-life | 10-12 hours | 
| Main action | Hypoglycemic agent | 
| Substance class | Sulfonylurea | 
| Formula | C15H21N3O3S | 
| Chemical name | 1-(3-azabicyclo[3.3.0]oct-3-yl)-3-(p-tolylsulfonyl)urea | 
| Trade name | Diamicron, among others | 
| Blood pressure | No significant impact on blood pressure | 
| WAREHOUSE | International Warehouse 2 | 
| Also known as | Glyclazide | 
| Lab Test | Blood glucose monitoring, hemoglobin A1c | 
| Aromatization | No | 
| Hepatotoxicity | No | 
| HBR | No | 
| Water Retention | No | 
| Acne | No | 
| Use in sports | Not typically used in sports | 
| Manufacturer | Servier | 





There are no reviews yet.